Carotid artery stenting is a procedure used to open a narrowed carotid artery in the heart. It involves placing a small, expandable or non-expandable tube called stent in the artery. The carotid artery stenting (CAS) procedure is also known as carotid angioplasty. Stenting helps in preventing a stroke in the long term, whereas it increases the risk of stroke and death in the short term. Carotid artery stenting is an optional procedure, which can be used if a patient has more than 60% to 70% narrowing and has low risk of serious problems from stenting. Carotid stents are available in different sizes and shapes in order to be used for patients with major heart problems. Carotid stents also feature few characteristics which makes these more useful devices for a heart surgeon. Characteristics such as visibility of stents under X-ray, scaffolding design for more effective drug elution and easier deliverability, and conformity of the stent struts to the vessel walls increase the safety and efficacy of these devices. However, new developments in stents technology are paving the way for earlier diagnosis and treatment of cardiovascular disease.
One of the major drivers for this market is Global burden of vascular diseases and stroke. The number of people affected by vascular diseases and stroke is increasing globally. CVDs are the main cause of death across the globe. The burden of CVDs is more prominent in emerging countries than in developed countries. Stroke and TIA are also prevalent globally and are responsible for a large number of deaths. The latest trend gaining momentum in the market is Increase in M&A. Companies are adopting M&A to expand their presence globally. They are also using this strategy to increase their product portfolio and market share. This strategy empowers organizations to juxtapose innovation with R&D abilities. The trade increases the opportunities for small organizations, as the larger organizations are constantly interested in acquiring them for their development prospects. M&A remain an important option for various medical device manufacturing companies.
North America contributes the majority of shares towards the carotid stents market during 2016. The market is witnessing growth in the Americas because the North American governments are taking measures to improve the healthcare outcomes and reduce the hospital expenditures. The carotid artery stenting market will continue to grow in the region throughout the forecasted period due to the presence of major manufacturers of carotid stents such as Abbott, Medtronic, and Boston Scientific in the Americas.
In 2019, the market size of Carotid Stents is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Carotid Stents.
This report studies the global market size of Carotid Stents, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Carotid Stents production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Abbott
Boston Scientific
Medtronic
Terumo
Balton
InspireMD
Optimed
W. L. Gore & Associates
Market Segment by Product Type
Balloon Expandable Stents
Self-Expanding Stents
Market Segment by Application
Ambulatory Surgical Units
Hospitals
Clinics
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Carotid Stents status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Carotid Stents manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Carotid Stents are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Summary:
Get latest Market Research Reports on Carotid Stents. Industry analysis & Market Report on Carotid Stents is a syndicated market report, published as Global (United States, European Union and China) Carotid Stents Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Carotid Stents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.